Invention Grant
- Patent Title: Fused thiazin-3-ones as KCA3.1 inhibitors
- Patent Title (中): 融合的噻嗪-3-酮作为KCA3.1抑制剂
-
Application No.: US14434671Application Date: 2013-06-12
-
Publication No.: US09533999B2Publication Date: 2017-01-03
- Inventor: Michael J. Burke , Bryan McKibben , Matt Aaron Tschantz
- Applicant: Boehringer Ingelheim International GmbH
- Applicant Address: DE Ingelheim am Rhein
- Assignee: Boehringer Ingelheim International GmbH
- Current Assignee: Boehringer Ingelheim International GmbH
- Current Assignee Address: DE Ingelheim am Rhein
- Agent Michael P. Morris; Atabak R. Royaee
- International Application: PCT/US2013/045405 WO 20130612
- International Announcement: WO2013/191984 WO 20131227
- Main IPC: C07D513/04
- IPC: C07D513/04
Abstract:
The present invention encompasses compounds of the formulas (I) & (II), wherein the groups A, L and Ar are defined as in claim 1, which are suitable for the treatment of diseases related to KCa3.1, process of making, pharmaceutical preparations which contain compounds and their methods of use.
Public/Granted literature
- US20150232484A1 FUSED THIAZIN-3-ONES AS KCA3.1 INHIBITORS Public/Granted day:2015-08-20
Information query
